Ledger.Open graph →
SEC Form D · filed September 3, 2015

Intellia Therapeutics, Inc

Offering
$70.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Carl Gordon · SAN FRANCISCO, CADirectorRachel Haurwitz · Berkeley, CADirectorNessan Bermingham · CAMBRIDGE, MAExec · DirectorJose Rivera · CAMBRIDGE, MAExecCarl Gordon · Encinitas, CADirectorJean-Francois Formela · Broomfield, CODirectorJohn Leonard · CAMBRIDGE, MAExec · DirectorNessan Bermingham · CAMBRIDGE, MAExec · DirectorJose Rivera · CAMBRIDGE, MAExecCarl Gordon · CAMBRIDGE, MADirectorJean-Francois Formela · Cambridge, MADirectorJohn Leonard · CAMBRIDGE, MAExec · DirectorRachel Haurwitz · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗